Patent · US Active

Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof

US11559576B2 · kind B2 · utility

1Cited by

2References

23Claims

0Family size

Assignee

REGENERON PHARMACEUTICALS, INC. · US

Inventors

Kevin A. Bray · Garnerville, US
Frank Delfino · Poughquag, US
Matthew C. Franklin · Great Neck, US
Elena S. Garnova · White Plains, US
Jessica R. Kirshner · New York, US
Douglas MacDonald · New York, US
William Olson · Ossining, US
Gavin Thurston · Briarcliff Manor, US

Key dates

Filing date	Aug 13, 2020
Grant date	Jan 24, 2023
Priority date	—
Expiry date	Jul 17, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/03
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides antigen-binding proteins that specifically bind to an HLA-displayed human papillomavirus (HPV) peptide, and therapeutic and diagnostic methods of using those binding proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.